Interestingly, recent studies have suggested that comorbidities such as hypercholesterolemia, prediabetes, and metabolic syndrome may impair cardioprotective interventions, including insulin treatment and ischemic pre- and postconditioning [43]. Here, INS is linked to prediabetes syndrome.